|
cardioprotective agent
Any protective agent that is able to prevent damage to the heart.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
vasodilator agent
A drug used to cause dilation of the blood vessels.
|
|
|
1,4-diazepane-1,4-diyldipropane-3,1-diyl bis(3,4,5-trimethoxybenzoate) dihydrochloride
|
(1,4- diazepane-1,4-diyl)di(propane-3,1-diyl) bis(3,4,5-trimethoxybenzoate)—hydrogen chloride (1/2)
|
IUPAC
|
|
1,4-bis[3-(3,4,5-trimethoxybenzoyloxy)propyl]homopiperazine dihydrochloride
|
ChEBI
|
|
1,4-bis{3-[(3,4,5-trimethoxybenzoyl)oxy]propyl}-1,4-diazepane-1,4-diium dichloride
|
IUPAC
|
|
1,4-bis{3-[(3,4,5-trimethoxybenzoyl)oxy]propyl}-1,4-diazepanediium dichloride
|
IUPAC
|
|
AS 05
|
ChemIDplus
|
|
ASTA C
|
ChemIDplus
|
|
ASTA C 4898
|
ChemIDplus
|
|
dilazep 2HCl
|
ChEBI
|
|
K-285
|
ChemIDplus
|
|
N,N'-bis(3-[3,4,5-trimethoxybenzoyloxy]propyl)homopiperazine dihydrochloride
|
ChEBI
|
